ASTH Stock Analysis

Astrana Health Inc
HEALTHCARE MEDICAL CARE FACILITIES

Back to Winners View Yahoo Finance Chart
Buy on the Dip
Strong Caution Mixed Weak Unavailable
StockValueFinder Grade
C-
55.89 / 100
Mixed
Confidence: Very High (97.0%) Coverage: 97.0%
Business Quality 37.1
Financial Strength 31.2
Earnings & Growth 88.7
Valuation 53.4
Market Strength 79.8
The grade combines Business Quality, Financial Strength, Earnings & Growth, Valuation, and Market Strength. Rating and Trend remain separate signals.
Rating AVOID
Avoid
The screening rules are warning against this setup.
Rating is the simple decision label from the screening rules.
Trend STRONG BUY TREND
Bullish
The available trend signal is constructive.
Trend shows whether price action is helping or hurting the setup.
P/E Ratio 45.12
High Expectations
Very high P/E requires strong future results to justify the price.
P/E shows how much investors pay for each dollar of earnings.
ROIC 1.21%
Weak
Low ROIC suggests limited profit efficiency.
ROIC measures how efficiently capital turns into profit.
Debt Payback 9.48 yrs
Weak
A long payback period can raise financial-risk concerns.
Debt payback estimates how quickly debt could be covered.
Interest Coverage 1.57x
Weak
Low coverage can make debt more risky.
Interest coverage shows how easily earnings cover interest costs.
Price $37.45
Market Price
Price alone is not a buy or sell signal.
Price should be judged with valuation, quality, and trend.
Last updated: 2026-10-25 19:34:47

Performance Overview

Trailing adjusted-close returns as of 2026-06-26. Benchmark is SPY.

YTD Return

ASTH +79.40%
SPY +7.47%

1-Year Return

ASTH +80.06%
SPY +20.46%

3-Year Return

ASTH +50.63%
SPY +75.39%

5-Year Return

ASTH -21.22%
SPY +82.87%

Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.

Legacy Screening Checks

This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.

17%
EPS Strength
FAIL

Looks for positive and improving earnings per share.

ROIC 10%+
FAIL

Looks for strong return on invested capital.

Interest Coverage 6+
FAIL

Checks whether operating income comfortably covers interest expense.

Debt Payback ≤ 3 Years
FAIL

Checks whether free cash flow could pay down long-term debt quickly.

P/E 15 or Less
FAIL

Checks whether valuation is reasonable under the current rule set.

Moving Average Trend
STRONG BUY TREND

Uses 20-day, 50-day, and 200-day moving averages for entry timing context.

A high StockValueFinder score is a research signal, not a guarantee. Strong companies can still fall during recessions, sector downturns, valuation resets, or company-specific events. Always review the business, risks, SEC filings, valuation, and your personal investment goals before buying.

Cached Technical Data

Moving average values from the latest stored scan.

20-Day MA36.92
50-Day MA37.36
200-Day MA33.61
MA Score5

Latest Published Stock Research

Research generated: October 24, 2026

ASTH Stock Analysis: Why Astrana Health Inc Scored 17% in Stock Value Finder

Astrana Health Inc (ASTH): A Comprehensive StockValueFinder Review

Astrana Health Inc is a healthcare company operating in the medical care facilities industry. This review aims to provide an educational analysis of ASTH's performance based on StockValueFinder metrics, focusing on financial health and valuation.

Why the StockValueFinder Score Matters StockValueFinder evaluates companies across multiple financial health indicators to determine an overall score that reflects their attractiveness as investment candidates. For Astrana Health Inc (ASTH), the current score is 17%, which falls into the "AVOID" category, indicating significant risks or weaknesses in its fundamentals.

EPS Strength and Consistency Earnings Per Share (EPS) consistency is a critical metric for evaluating a company's financial health and growth potential. A stable and increasing EPS over time suggests that the company can generate consistent profits and invest in future opportunities effectively.

**Supplied Fact:** Did not pass - **Explanation:** StockValueFinder requires companies to demonstrate strong earnings stability, typically through several years of positive EPS growth. Without detailed historical data on EPS trends for ASTH, we cannot determine specific values or patterns. However, the system flagged ASTH as failing this test, suggesting potential issues with earnings reliability.

ROIC and Capital Efficiency Return On Invested Capital (ROIC) measures how efficiently a company uses its capital to generate profits. A higher ROIC indicates better use of resources and stronger competitive positioning.

**Supplied Fact:** 1.21% - **Strong Range:** Preferably above 10% - **Weak Range:** Below 5% - **Explanation:** ASTH's ROIC is at a low 1.21%, which falls well below the preferred range of 10% or higher. This suggests that the company may be struggling to generate sufficient returns on its capital investments, indicating inefficient use of resources and potentially weaker competitive standing.

Interest Coverage and Financial Safety Interest coverage ratio measures a company's ability to meet interest obligations with earnings before interest and taxes (EBIT). A higher ratio indicates stronger financial stability.

**Supplied Fact:** Did not pass - **Strong Range:** 6 or higher - **Weak Range:** Below 3 - **Explanation:** The system flagged ASTH as failing the interest coverage test, indicating that its ability to cover interest expenses may be insufficient. This suggests potential risks related to debt servicing and financial stability.

Debt Payback and Balance Sheet Discipline Debt payback period reflects how long it would take a company to repay all of its outstanding debt using current earnings before interest and taxes (EBIT). A shorter period indicates better balance sheet health.

**Supplied Fact:** 9.48 years - **Strong Range:** 3 years or less - **Weak Range:** More than 5 years - **Explanation:** ASTH's debt payback period of 9.48 years is significantly longer than the preferred range, indicating that it would take a considerable amount of time to repay its debts. This suggests potential liquidity and solvency risks.

P/E Ratio and Valuation Discipline The Price-to-Earnings (P/E) ratio measures how much investors are willing to pay for each dollar of earnings. A lower P/E typically indicates better value, assuming the company's fundamentals are sound.

**Supplied Fact:** 45.67 - **Strong Range:** Below 15 - **Weak Range:** Above 30 - **Explanation:** ASTH has a high P/E ratio of 45.67, which is well above the preferred range of 15 or lower. This suggests that the stock may be overvalued relative to its earnings performance.

Moving Average Trend and Entry Timing The moving average trend signal provides insights into the current market sentiment towards the stock based on price movements over time. However, it should not be viewed as a guarantee of future returns but rather as an indicator for timing discipline.

**Supplied Fact:** STRONG BUY TREND - **Entry Signal:** N/A - **Explanation:** While StockValueFinder indicates a strong buy trend, the entry signal is not provided, meaning there are no specific price levels recommended for buying or selling. This suggests that while market sentiment may be positive, investors should still exercise caution due to the company's underlying financial weaknesses.

Overall Financial Strengths and Weaknesses **Strengths:** - **Moving Average Trend:** Positive trend signal indicating potential short-term momentum.

**Weaknesses:** - **EPS Consistency:** Lack of consistent earnings growth or stability. - **ROIC Efficiency:** Poor capital efficiency with a low ROIC. - **Interest Coverage:** Insufficient ability to cover interest expenses. - **Debt Payback Period:** Long period needed to repay debt, indicating liquidity risks. - **P/E Ratio:** High valuation relative to earnings.

Risks and Limitations Investing in ASTH carries significant financial risks due to its poor EPS consistency, low ROIC, insufficient interest coverage, lengthy debt payback period, and high P/E ratio. These factors collectively suggest that the company may struggle with capital efficiency, liquidity management, and market valuation, posing substantial challenges for investors.

Educational Conclusion This review of Astrana Health Inc (ASTH) highlights the importance of evaluating multiple financial metrics to assess a stock's overall attractiveness and risk profile. By understanding EPS consistency, ROIC, interest coverage, debt payback period, P/E ratio, and moving average trends, investors can make more informed decisions about potential investments.

This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.

Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings

Research Attribution
Max Qwen II

Specializing in monetary economics, market incentives, and investment risk.

AI-assisted research generated October 24, 2026

30-Day Trendline Analysis

Optional intraday chart with rising support, falling resistance, and multi-timeframe views.

Load detailed price structure only when needed. Downloads roughly 30 days of 5-minute candles, identifies swing points, then calculates validated support and resistance lines.
Scroll to Top